{"entity":{"type":"insider","cik":"0001517775","url":"/insider/0001517775","json_url":"/insider/0001517775.json","name":"LEE WILLIS C","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":85,"n_filings":32,"first":"2019-08-23","last":"2024-02-29","span_basis":"filed_date"},"name_variants":[{"name":"LEE WILLIS C","source":"filing","n_filings":32,"first_seen":"2019-08-23","last_seen":"2024-02-29"}],"transactions":[{"id":2738920,"accession":"0001209191-24-004124","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-24-004124","line_url":"/filing/0001209191-24-004124#line-4","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517775","owner_name":"LEE WILLIS C","owner_display_name":"LEE WILLIS C","owner_url":"/insider/0001517775","role":"Director, Officer (Co-President & COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Co-President & COO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":77000.0,"shares_display":"77,000","price_per_share":0.13,"price_display":"0.13","price_state":"stated","total_value":10010.0,"total_display":"10,010.00","total_whole":"10,010","shares_owned_after":159400.0,"shares_owned_after_display":"159,400","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-02-29","filed_date":"2024-02-29","scope":"insider"},{"id":2738915,"accession":"0001209191-24-004124","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-24-004124","line_url":"/filing/0001209191-24-004124#line-3","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517775","owner_name":"LEE WILLIS C","owner_display_name":"LEE WILLIS C","owner_url":"/insider/0001517775","role":"Director, Officer (Co-President & COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Co-President & COO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":0.12,"price_display":"0.12","price_state":"stated","total_value":1800.0,"total_display":"1,800.00","total_whole":"1,800","shares_owned_after":82400.0,"shares_owned_after_display":"82,400","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-02-28","filed_date":"2024-02-29","scope":"insider"},{"id":2738912,"accession":"0001209191-24-004124","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-24-004124","line_url":"/filing/0001209191-24-004124#line-2","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517775","owner_name":"LEE WILLIS C","owner_display_name":"LEE WILLIS C","owner_url":"/insider/0001517775","role":"Director, Officer (Co-President & COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Co-President & COO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.13,"price_display":"0.13","price_state":"stated","total_value":1300.0,"total_display":"1,300.00","total_whole":"1,300","shares_owned_after":67400.0,"shares_owned_after_display":"67,400","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-02-27","filed_date":"2024-02-29","scope":"insider"},{"id":2738906,"accession":"0001209191-24-004124","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-24-004124","line_url":"/filing/0001209191-24-004124#line-1","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517775","owner_name":"LEE WILLIS C","owner_display_name":"LEE WILLIS C","owner_url":"/insider/0001517775","role":"Director, Officer (Co-President & COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Co-President & COO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13200.0,"shares_display":"13,200","price_per_share":0.12,"price_display":"0.12","price_state":"stated","total_value":1584.0,"total_display":"1,584.00","total_whole":"1,584","shares_owned_after":57400.0,"shares_owned_after_display":"57,400","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-02-26","filed_date":"2024-02-29","scope":"insider"},{"id":9272088,"accession":"0001209191-24-000442","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-24-000442","line_url":"/filing/0001209191-24-000442#line-6","is_derivative":false,"issuer_cik":"0001517775","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0001517775","owner_cik":"0001517775","owner_name":"LEE WILLIS C","owner_display_name":"LEE WILLIS C","owner_url":"/insider/0001517775","role":"Director, Officer (COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":59400.0,"shares_display":"59,400","price_per_share":0.12,"price_display":"0.12","price_state":"stated","total_value":7128.0,"total_display":"7,128.00","total_whole":"7,128","shares_owned_after":395124.0,"shares_owned_after_display":"395,124","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-30","filed_date":"2024-01-03","scope":"insider"},{"id":7900252,"accession":"0001209191-23-057328","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-23-057328","line_url":"/filing/0001209191-23-057328#line-6","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517775","owner_name":"LEE WILLIS C","owner_display_name":"LEE WILLIS C","owner_url":"/insider/0001517775","role":"Director, Officer (COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7417.0,"shares_display":"7,417","price_per_share":0.12,"price_display":"0.12","price_state":"stated","total_value":890.04,"total_display":"890.04","total_whole":"890","shares_owned_after":395124.0,"shares_owned_after_display":"395,124","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-30","filed_date":"2023-12-04","scope":"insider"},{"id":9272090,"accession":"0001209191-24-000442","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-24-000442","line_url":"/filing/0001209191-24-000442#line-5","is_derivative":false,"issuer_cik":"0001517775","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0001517775","owner_cik":"0001517775","owner_name":"LEE WILLIS C","owner_display_name":"LEE WILLIS C","owner_url":"/insider/0001517775","role":"Director, Officer (COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":36000.0,"shares_display":"36,000","price_per_share":0.12,"price_display":"0.12","price_state":"stated","total_value":4320.0,"total_display":"4,320.00","total_whole":"4,320","shares_owned_after":335724.0,"shares_owned_after_display":"335,724","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-29","filed_date":"2024-01-03","scope":"insider"},{"id":7900246,"accession":"0001209191-23-057328","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-23-057328","line_url":"/filing/0001209191-23-057328#line-5","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517775","owner_name":"LEE WILLIS C","owner_display_name":"LEE WILLIS C","owner_url":"/insider/0001517775","role":"Director, Officer (COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4325.0,"shares_display":"4,325","price_per_share":0.12,"price_display":"0.12","price_state":"stated","total_value":519.0,"total_display":"519.00","total_whole":"519","shares_owned_after":335724.0,"shares_owned_after_display":"335,724","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-29","filed_date":"2023-12-04","scope":"insider"},{"id":9272091,"accession":"0001209191-24-000442","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-24-000442","line_url":"/filing/0001209191-24-000442#line-4","is_derivative":false,"issuer_cik":"0001517775","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0001517775","owner_cik":"0001517775","owner_name":"LEE WILLIS C","owner_display_name":"LEE WILLIS C","owner_url":"/insider/0001517775","role":"Director, Officer (COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12000.0,"shares_display":"12,000","price_per_share":0.12,"price_display":"0.12","price_state":"stated","total_value":1440.0,"total_display":"1,440.00","total_whole":"1,440","shares_owned_after":299724.0,"shares_owned_after_display":"299,724","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-28","filed_date":"2024-01-03","scope":"insider"},{"id":7900241,"accession":"0001209191-23-057328","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-057328","line_url":"/filing/0001209191-23-057328#line-4","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517775","owner_name":"LEE WILLIS C","owner_display_name":"LEE WILLIS C","owner_url":"/insider/0001517775","role":"Director, Officer (COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1470.0,"shares_display":"1,470","price_per_share":0.12,"price_display":"0.12","price_state":"stated","total_value":176.4,"total_display":"176.40","total_whole":"176","shares_owned_after":299724.0,"shares_owned_after_display":"299,724","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-28","filed_date":"2023-12-04","scope":"insider"},{"id":9272092,"accession":"0001209191-24-000442","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-24-000442","line_url":"/filing/0001209191-24-000442#line-3","is_derivative":false,"issuer_cik":"0001517775","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0001517775","owner_cik":"0001517775","owner_name":"LEE WILLIS C","owner_display_name":"LEE WILLIS C","owner_url":"/insider/0001517775","role":"Director, Officer (COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1100.0,"shares_display":"1,100","price_per_share":0.12,"price_display":"0.12","price_state":"stated","total_value":132.0,"total_display":"132.00","total_whole":"132","shares_owned_after":44200.0,"shares_owned_after_display":"44,200","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-14","filed_date":"2024-01-03","scope":"insider"},{"id":7900236,"accession":"0001209191-23-057328","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-057328","line_url":"/filing/0001209191-23-057328#line-3","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517775","owner_name":"LEE WILLIS C","owner_display_name":"LEE WILLIS C","owner_url":"/insider/0001517775","role":"Director, Officer (COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":132.0,"shares_display":"132","price_per_share":0.12,"price_display":"0.12","price_state":"stated","total_value":15.84,"total_display":"15.84","total_whole":"16","shares_owned_after":44200.0,"shares_owned_after_display":"44,200","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-14","filed_date":"2023-12-04","scope":"insider"},{"id":9272093,"accession":"0001209191-24-000442","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-24-000442","line_url":"/filing/0001209191-24-000442#line-2","is_derivative":false,"issuer_cik":"0001517775","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0001517775","owner_cik":"0001517775","owner_name":"LEE WILLIS C","owner_display_name":"LEE WILLIS C","owner_url":"/insider/0001517775","role":"Director, Officer (COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":0.15,"price_display":"0.15","price_state":"stated","total_value":900.0,"total_display":"900.00","total_whole":"900","shares_owned_after":43100.0,"shares_owned_after_display":"43,100","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-31","filed_date":"2024-01-03","scope":"insider"},{"id":7900228,"accession":"0001209191-23-057328","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-057328","line_url":"/filing/0001209191-23-057328#line-2","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517775","owner_name":"LEE WILLIS C","owner_display_name":"LEE WILLIS C","owner_url":"/insider/0001517775","role":"Director, Officer (COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":900.0,"shares_display":"900","price_per_share":0.15,"price_display":"0.15","price_state":"stated","total_value":135.0,"total_display":"135.00","total_whole":"135","shares_owned_after":43100.0,"shares_owned_after_display":"43,100","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-31","filed_date":"2023-12-04","scope":"insider"},{"id":9272089,"accession":"0001209191-24-000442","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-24-000442","line_url":"/filing/0001209191-24-000442#line-1","is_derivative":false,"issuer_cik":"0001517775","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0001517775","owner_cik":"0001517775","owner_name":"LEE WILLIS C","owner_display_name":"LEE WILLIS C","owner_url":"/insider/0001517775","role":"Director, Officer (COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6500.0,"shares_display":"6,500","price_per_share":0.21,"price_display":"0.21","price_state":"stated","total_value":1365.0,"total_display":"1,365.00","total_whole":"1,365","shares_owned_after":37100.0,"shares_owned_after_display":"37,100","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-25","filed_date":"2024-01-03","scope":"insider"},{"id":7900222,"accession":"0001209191-23-057328","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-057328","line_url":"/filing/0001209191-23-057328#line-1","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517775","owner_name":"LEE WILLIS C","owner_display_name":"LEE WILLIS C","owner_url":"/insider/0001517775","role":"Director, Officer (COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1365.0,"shares_display":"1,365","price_per_share":0.21,"price_display":"0.21","price_state":"stated","total_value":286.65,"total_display":"286.65","total_whole":"287","shares_owned_after":37100.0,"shares_owned_after_display":"37,100","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-25","filed_date":"2023-12-04","scope":"insider"},{"id":8607717,"accession":"0001209191-23-033573","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-033573","line_url":"/filing/0001209191-23-033573#line-2","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517775","owner_name":"LEE WILLIS C","owner_display_name":"LEE WILLIS C","owner_url":"/insider/0001517775","role":"Director, Officer (COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":28700.0,"shares_display":"28,700","price_per_share":0.29,"price_display":"0.29","price_state":"stated","total_value":8323.0,"total_display":"8,323.00","total_whole":"8,323","shares_owned_after":30600.0,"shares_owned_after_display":"30,600","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-31","filed_date":"2023-06-02","scope":"insider"},{"id":8607713,"accession":"0001209191-23-033573","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-033573","line_url":"/filing/0001209191-23-033573#line-1","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517775","owner_name":"LEE WILLIS C","owner_display_name":"LEE WILLIS C","owner_url":"/insider/0001517775","role":"Director, Officer (COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":750.0,"shares_display":"750","price_per_share":0.28,"price_display":"0.28","price_state":"stated","total_value":210.0,"total_display":"210.00","total_whole":"210","shares_owned_after":287724.0,"shares_owned_after_display":"287,724","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-20","filed_date":"2023-06-02","scope":"insider"},{"id":6277158,"accession":"0001209191-22-043081","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-043081","line_url":"/filing/0001209191-22-043081#line-1","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517775","owner_name":"LEE WILLIS C","owner_display_name":"LEE WILLIS C","owner_url":"/insider/0001517775","role":"Director, Officer (COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3200.0,"shares_display":"3,200","price_per_share":0.39,"price_display":"0.39","price_state":"stated","total_value":1248.0,"total_display":"1,248.00","total_whole":"1,248","shares_owned_after":286974.0,"shares_owned_after_display":"286,974","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-19","filed_date":"2022-07-25","scope":"insider"},{"id":6125610,"accession":"0001209191-22-033847","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-033847","line_url":"/filing/0001209191-22-033847#line-2","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517775","owner_name":"LEE WILLIS C","owner_display_name":"LEE WILLIS C","owner_url":"/insider/0001517775","role":"Director, Officer (Director & COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Director & COO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":0.4,"price_display":"0.40","price_state":"stated","total_value":1000.0,"total_display":"1,000.00","total_whole":"1,000","shares_owned_after":283774.0,"shares_owned_after_display":"283,774","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-31","filed_date":"2022-06-03","scope":"insider"},{"id":6125607,"accession":"0001209191-22-033847","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-033847","line_url":"/filing/0001209191-22-033847#line-1","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517775","owner_name":"LEE WILLIS C","owner_display_name":"LEE WILLIS C","owner_url":"/insider/0001517775","role":"Director, Officer (Director & COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Director & COO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":0.37,"price_display":"0.37","price_state":"stated","total_value":925.0,"total_display":"925.00","total_whole":"925","shares_owned_after":281274.0,"shares_owned_after_display":"281,274","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-27","filed_date":"2022-06-03","scope":"insider"},{"id":6698490,"accession":"0001209191-22-024129","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-22-024129","line_url":"/filing/0001209191-22-024129#line-4","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517775","owner_name":"LEE WILLIS C","owner_display_name":"LEE WILLIS C","owner_url":"/insider/0001517775","role":"Director, Officer (Director & COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Director & COO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8900.0,"shares_display":"8,900","price_per_share":0.88,"price_display":"0.88","price_state":"stated","total_value":7832.0,"total_display":"7,832.00","total_whole":"7,832","shares_owned_after":278774.0,"shares_owned_after_display":"278,774","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-11","filed_date":"2022-04-12","scope":"insider"},{"id":6698488,"accession":"0001209191-22-024129","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-024129","line_url":"/filing/0001209191-22-024129#line-3","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517775","owner_name":"LEE WILLIS C","owner_display_name":"LEE WILLIS C","owner_url":"/insider/0001517775","role":"Director, Officer (Director & COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Director & COO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1600.0,"shares_display":"1,600","price_per_share":0.76,"price_display":"0.76","price_state":"stated","total_value":1216.0,"total_display":"1,216.00","total_whole":"1,216","shares_owned_after":241194.0,"shares_owned_after_display":"241,194","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-08","filed_date":"2022-04-12","scope":"insider"},{"id":6698485,"accession":"0001209191-22-024129","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-024129","line_url":"/filing/0001209191-22-024129#line-2","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517775","owner_name":"LEE WILLIS C","owner_display_name":"LEE WILLIS C","owner_url":"/insider/0001517775","role":"Director, Officer (Director & COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Director & COO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1400.0,"shares_display":"1,400","price_per_share":0.95,"price_display":"0.95","price_state":"stated","total_value":1330.0,"total_display":"1,330.00","total_whole":"1,330","shares_owned_after":239594.0,"shares_owned_after_display":"239,594","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-06","filed_date":"2022-04-12","scope":"insider"},{"id":6698483,"accession":"0001209191-22-024129","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-024129","line_url":"/filing/0001209191-22-024129#line-1","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517775","owner_name":"LEE WILLIS C","owner_display_name":"LEE WILLIS C","owner_url":"/insider/0001517775","role":"Director, Officer (Director & COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Director & COO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3200.0,"shares_display":"3,200","price_per_share":0.98,"price_display":"0.98","price_state":"stated","total_value":3136.0,"total_display":"3,136.00","total_whole":"3,136","shares_owned_after":238194.0,"shares_owned_after_display":"238,194","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-04","filed_date":"2022-04-12","scope":"insider"},{"id":6723150,"accession":"0001209191-22-013725","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-22-013725","line_url":"/filing/0001209191-22-013725","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517775","owner_name":"LEE WILLIS C","owner_display_name":"LEE WILLIS C","owner_url":"/insider/0001517775","role":"Director, Officer (Vice Chairman & COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice Chairman & COO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14700.0,"shares_display":"14,700","price_per_share":1.5140816326530613,"price_display":"1.51","price_state":"stated","total_value":22257.0,"total_display":"22,257.00","total_whole":"22,257","shares_owned_after":269874.0,"shares_owned_after_display":"269,874","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-28","filed_date":"2022-02-28","scope":"insider","n_lines":3},{"id":6723140,"accession":"0001209191-22-013725","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-013725","line_url":"/filing/0001209191-22-013725#line-2","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517775","owner_name":"LEE WILLIS C","owner_display_name":"LEE WILLIS C","owner_url":"/insider/0001517775","role":"Director, Officer (Vice Chairman & COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice Chairman & COO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5900.0,"shares_display":"5,900","price_per_share":1.44,"price_display":"1.44","price_state":"stated","total_value":8496.0,"total_display":"8,496.00","total_whole":"8,496","shares_owned_after":262674.0,"shares_owned_after_display":"262,674","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-24","filed_date":"2022-02-28","scope":"insider"},{"id":6723138,"accession":"0001209191-22-013725","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-013725","line_url":"/filing/0001209191-22-013725#line-1","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517775","owner_name":"LEE WILLIS C","owner_display_name":"LEE WILLIS C","owner_url":"/insider/0001517775","role":"Director, Officer (Vice Chairman & COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice Chairman & COO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":1.42,"price_display":"1.42","price_state":"stated","total_value":710.0,"total_display":"710.00","total_whole":"710","shares_owned_after":256774.0,"shares_owned_after_display":"256,774","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-22","filed_date":"2022-02-28","scope":"insider"},{"id":6888709,"accession":"0001209191-22-001426","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-22-001426","line_url":"/filing/0001209191-22-001426#line-4","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517775","owner_name":"LEE WILLIS C","owner_display_name":"LEE WILLIS C","owner_url":"/insider/0001517775","role":"Director, Officer (Vice Chairman & COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice Chairman & COO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":1.5,"price_display":"1.50","price_state":"stated","total_value":750.0,"total_display":"750.00","total_whole":"750","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-17","filed_date":"2022-01-05","scope":"insider"},{"id":6888705,"accession":"0001209191-22-001426","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-001426","line_url":"/filing/0001209191-22-001426#line-3","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517775","owner_name":"LEE WILLIS C","owner_display_name":"LEE WILLIS C","owner_url":"/insider/0001517775","role":"Director, Officer (Vice Chairman & COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice Chairman & COO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":1.52,"price_display":"1.52","price_state":"stated","total_value":760.0,"total_display":"760.00","total_whole":"760","shares_owned_after":500.0,"shares_owned_after_display":"500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-13","filed_date":"2022-01-05","scope":"insider"},{"id":6888700,"accession":"0001209191-22-001426","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-001426","line_url":"/filing/0001209191-22-001426#line-2","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517775","owner_name":"LEE WILLIS C","owner_display_name":"LEE WILLIS C","owner_url":"/insider/0001517775","role":"Director, Officer (Vice Chairman & COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice Chairman & COO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":1.74,"price_display":"1.74","price_state":"stated","total_value":348.0,"total_display":"348.00","total_whole":"348","shares_owned_after":256274.0,"shares_owned_after_display":"256,274","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-10","filed_date":"2022-01-05","scope":"insider"},{"id":6888694,"accession":"0001209191-22-001426","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-001426","line_url":"/filing/0001209191-22-001426#line-1","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517775","owner_name":"LEE WILLIS C","owner_display_name":"LEE WILLIS C","owner_url":"/insider/0001517775","role":"Director, Officer (Vice Chairman & COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice Chairman & COO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":1.54,"price_display":"1.54","price_state":"stated","total_value":770.0,"total_display":"770.00","total_whole":"770","shares_owned_after":256074.0,"shares_owned_after_display":"256,074","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-03","filed_date":"2022-01-05","scope":"insider"},{"id":4678843,"accession":"0001209191-21-067167","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-067167","line_url":"/filing/0001209191-21-067167#line-3","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517775","owner_name":"LEE WILLIS C","owner_display_name":"LEE WILLIS C","owner_url":"/insider/0001517775","role":"Director, Officer (Vice Chairman & COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice Chairman & COO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15500.0,"shares_display":"15,500","price_per_share":1.5,"price_display":"1.50","price_state":"stated","total_value":23250.0,"total_display":"23,250.00","total_whole":"23,250","shares_owned_after":228394.0,"shares_owned_after_display":"228,394","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-30","filed_date":"2021-11-30","scope":"insider"},{"id":4678838,"accession":"0001209191-21-067167","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-067167","line_url":"/filing/0001209191-21-067167#line-2","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517775","owner_name":"LEE WILLIS C","owner_display_name":"LEE WILLIS C","owner_url":"/insider/0001517775","role":"Director, Officer (Vice Chairman & COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice Chairman & COO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15705.0,"shares_display":"15,705","price_per_share":1.47,"price_display":"1.47","price_state":"stated","total_value":23086.35,"total_display":"23,086.35","total_whole":"23,086","shares_owned_after":212894.0,"shares_owned_after_display":"212,894","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-29","filed_date":"2021-11-30","scope":"insider"},{"id":4678831,"accession":"0001209191-21-067167","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-067167","line_url":"/filing/0001209191-21-067167#line-1","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517775","owner_name":"LEE WILLIS C","owner_display_name":"LEE WILLIS C","owner_url":"/insider/0001517775","role":"Director, Officer (Vice Chairman & COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice Chairman & COO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":24328.0,"shares_display":"24,328","price_per_share":1.45,"price_display":"1.45","price_state":"stated","total_value":35275.6,"total_display":"35,275.60","total_whole":"35,276","shares_owned_after":197189.0,"shares_owned_after_display":"197,189","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-26","filed_date":"2021-11-30","scope":"insider"},{"id":4904251,"accession":"0001209191-21-066920","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-066920","line_url":"/filing/0001209191-21-066920#line-2","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517775","owner_name":"LEE WILLIS C","owner_display_name":"LEE WILLIS C","owner_url":"/insider/0001517775","role":"Director, Officer (Vice Chairman & COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice Chairman & COO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":34500.0,"shares_display":"34,500","price_per_share":1.34,"price_display":"1.34","price_state":"stated","total_value":46230.0,"total_display":"46,230.00","total_whole":"46,230","shares_owned_after":172861.0,"shares_owned_after_display":"172,861","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-24","filed_date":"2021-11-26","scope":"insider"},{"id":4904246,"accession":"0001209191-21-066920","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-066920","line_url":"/filing/0001209191-21-066920#line-1","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517775","owner_name":"LEE WILLIS C","owner_display_name":"LEE WILLIS C","owner_url":"/insider/0001517775","role":"Director, Officer (Vice Chairman & COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice Chairman & COO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3500.0,"shares_display":"3,500","price_per_share":1.32,"price_display":"1.32","price_state":"stated","total_value":4620.0,"total_display":"4,620.00","total_whole":"4,620","shares_owned_after":138361.0,"shares_owned_after_display":"138,361","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-23","filed_date":"2021-11-26","scope":"insider"},{"id":4237938,"accession":"0001209191-21-066428","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-21-066428","line_url":"/filing/0001209191-21-066428#line-5","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517775","owner_name":"LEE WILLIS C","owner_display_name":"LEE WILLIS C","owner_url":"/insider/0001517775","role":"Director, Officer (Vice Chairman & COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice Chairman & COO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8900.0,"shares_display":"8,900","price_per_share":1.44,"price_display":"1.44","price_state":"stated","total_value":12816.0,"total_display":"12,816.00","total_whole":"12,816","shares_owned_after":134861.0,"shares_owned_after_display":"134,861","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-22","filed_date":"2021-11-23","scope":"insider"},{"id":4237928,"accession":"0001209191-21-066428","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-066428","line_url":"/filing/0001209191-21-066428#line-4","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517775","owner_name":"LEE WILLIS C","owner_display_name":"LEE WILLIS C","owner_url":"/insider/0001517775","role":"Director, Officer (Vice Chairman & COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice Chairman & COO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.37,"price_display":"1.37","price_state":"stated","total_value":6850.0,"total_display":"6,850.00","total_whole":"6,850","shares_owned_after":125961.0,"shares_owned_after_display":"125,961","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-19","filed_date":"2021-11-23","scope":"insider"},{"id":4237925,"accession":"0001209191-21-066428","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-066428","line_url":"/filing/0001209191-21-066428#line-3","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517775","owner_name":"LEE WILLIS C","owner_display_name":"LEE WILLIS C","owner_url":"/insider/0001517775","role":"Director, Officer (Vice Chairman & COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice Chairman & COO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":1.29,"price_display":"1.29","price_state":"stated","total_value":1290.0,"total_display":"1,290.00","total_whole":"1,290","shares_owned_after":120961.0,"shares_owned_after_display":"120,961","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-17","filed_date":"2021-11-23","scope":"insider"},{"id":4237920,"accession":"0001209191-21-066428","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-066428","line_url":"/filing/0001209191-21-066428#line-2","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517775","owner_name":"LEE WILLIS C","owner_display_name":"LEE WILLIS C","owner_url":"/insider/0001517775","role":"Director, Officer (Vice Chairman & COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice Chairman & COO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2100.0,"shares_display":"2,100","price_per_share":1.29,"price_display":"1.29","price_state":"stated","total_value":2709.0,"total_display":"2,709.00","total_whole":"2,709","shares_owned_after":119961.0,"shares_owned_after_display":"119,961","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-16","filed_date":"2021-11-23","scope":"insider"},{"id":4237915,"accession":"0001209191-21-066428","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-066428","line_url":"/filing/0001209191-21-066428#line-1","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517775","owner_name":"LEE WILLIS C","owner_display_name":"LEE WILLIS C","owner_url":"/insider/0001517775","role":"Director, Officer (Vice Chairman & COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice Chairman & COO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1600.0,"shares_display":"1,600","price_per_share":1.24,"price_display":"1.24","price_state":"stated","total_value":1984.0,"total_display":"1,984.00","total_whole":"1,984","shares_owned_after":117861.0,"shares_owned_after_display":"117,861","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-15","filed_date":"2021-11-23","scope":"insider"},{"id":5384308,"accession":"0001209191-21-056785","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-056785","line_url":"/filing/0001209191-21-056785#line-3","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517775","owner_name":"LEE WILLIS C","owner_display_name":"LEE WILLIS C","owner_url":"/insider/0001517775","role":"Director, Officer (Vice Chairman & COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice Chairman & COO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":1.71,"price_display":"1.71","price_state":"stated","total_value":855.0,"total_display":"855.00","total_whole":"855","shares_owned_after":116261.0,"shares_owned_after_display":"116,261","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-17","filed_date":"2021-09-17","scope":"insider"},{"id":5384305,"accession":"0001209191-21-056785","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-056785","line_url":"/filing/0001209191-21-056785#line-2","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517775","owner_name":"LEE WILLIS C","owner_display_name":"LEE WILLIS C","owner_url":"/insider/0001517775","role":"Director, Officer (Vice Chairman & COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice Chairman & COO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":1.71,"price_display":"1.71","price_state":"stated","total_value":1710.0,"total_display":"1,710.00","total_whole":"1,710","shares_owned_after":115761.0,"shares_owned_after_display":"115,761","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-16","filed_date":"2021-09-17","scope":"insider"},{"id":5384303,"accession":"0001209191-21-056785","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-056785","line_url":"/filing/0001209191-21-056785#line-1","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517775","owner_name":"LEE WILLIS C","owner_display_name":"LEE WILLIS C","owner_url":"/insider/0001517775","role":"Director, Officer (Vice Chairman & COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice Chairman & COO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":1.51,"price_display":"1.51","price_state":"stated","total_value":3020.0,"total_display":"3,020.00","total_whole":"3,020","shares_owned_after":114761.0,"shares_owned_after_display":"114,761","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-15","filed_date":"2021-09-17","scope":"insider"},{"id":4427583,"accession":"0001209191-21-055547","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-055547","line_url":"/filing/0001209191-21-055547#line-2","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517775","owner_name":"LEE WILLIS C","owner_display_name":"LEE WILLIS C","owner_url":"/insider/0001517775","role":"Director, Officer (Vice Chairman & COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice Chairman & COO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":1.72,"price_display":"1.72","price_state":"stated","total_value":3440.0,"total_display":"3,440.00","total_whole":"3,440","shares_owned_after":112761.0,"shares_owned_after_display":"112,761","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-10","filed_date":"2021-09-10","scope":"insider"},{"id":4427578,"accession":"0001209191-21-055547","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-055547","line_url":"/filing/0001209191-21-055547#line-1","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517775","owner_name":"LEE WILLIS C","owner_display_name":"LEE WILLIS C","owner_url":"/insider/0001517775","role":"Director, Officer (Vice Chairman & COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice Chairman & COO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":1.7,"price_display":"1.70","price_state":"stated","total_value":3400.0,"total_display":"3,400.00","total_whole":"3,400","shares_owned_after":110761.0,"shares_owned_after_display":"110,761","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-08","filed_date":"2021-09-10","scope":"insider"},{"id":5478065,"accession":"0001209191-21-053681","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-053681","line_url":"/filing/0001209191-21-053681#line-3","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517775","owner_name":"LEE WILLIS C","owner_display_name":"LEE WILLIS C","owner_url":"/insider/0001517775","role":"Director, Officer (Vice Chairman & COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice Chairman & COO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500.0,"shares_display":"1,500","price_per_share":1.54,"price_display":"1.54","price_state":"stated","total_value":2310.0,"total_display":"2,310.00","total_whole":"2,310","shares_owned_after":255574.0,"shares_owned_after_display":"255,574","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-27","filed_date":"2021-08-27","scope":"insider"}],"collapsed":true,"next_cursor":"2021-08-27|5478065","ledger_fault":false,"count":{"value":85,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":85,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":85},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000822370","name":"Emmaus Life Sciences, Inc.","url":"/issuer/0000822370","role":"Director, Officer (Co-President & COO)","n_filings":32,"first_seen":"2019-08-23","last_seen":"2024-02-29"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001517775","retrieved_at":"2026-08-27T17:08:36+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}